These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 9794451)

  • 21. Multisite regulation of insulin secretion by cAMP-increasing agonists: evidence that glucagon-like peptide 1 and glucagon act via distinct receptors.
    Gromada J; Ding WG; Barg S; Renström E; Rorsman P
    Pflugers Arch; 1997 Sep; 434(5):515-24. PubMed ID: 9242714
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impaired cyclic AMP response to stimuli in glucose-desensitized rat pancreatic islets.
    Laychock SG
    Mol Cell Endocrinol; 1995 Aug; 113(1):19-28. PubMed ID: 8674810
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glucagon-like peptide-1 (GLP-1) and glucose metabolism in human myocytes.
    Luque MA; González N; Márquez L; Acitores A; Redondo A; Morales M; Valverde I; Villanueva-Peñacarrillo ML
    J Endocrinol; 2002 Jun; 173(3):465-73. PubMed ID: 12065236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glucagon-like peptide-1 improves insulin and proinsulin binding on RINm5F cells and human monocytes.
    Ebinger M; Jehle DR; Fussgaenger RD; Fehmann HC; Jehle PM
    Am J Physiol Endocrinol Metab; 2000 Jul; 279(1):E88-94. PubMed ID: 10893327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glucagon-like peptide-1 receptor signaling modulates beta cell apoptosis.
    Li Y; Hansotia T; Yusta B; Ris F; Halban PA; Drucker DJ
    J Biol Chem; 2003 Jan; 278(1):471-8. PubMed ID: 12409292
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Desensitization and phosphorylation of the glucagon-like peptide-1 (GLP-1) receptor by GLP-1 and 4-phorbol 12-myristate 13-acetate.
    Widmann C; Dolci W; Thorens B
    Mol Endocrinol; 1996 Jan; 10(1):62-75. PubMed ID: 8838146
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distribution of glucagon receptors on hormone-specific endocrine cells of rat pancreatic islets.
    Kieffer TJ; Heller RS; Unson CG; Weir GC; Habener JF
    Endocrinology; 1996 Nov; 137(11):5119-25. PubMed ID: 8895386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glucagon-like peptide-1-(7-36)amide and a rise in cyclic adenosine 3',5'-monophosphate increase cytosolic free Ca2+ in rat pancreatic beta-cells by enhancing Ca2+ channel activity.
    Yada T; Itoh K; Nakata M
    Endocrinology; 1993 Oct; 133(4):1685-92. PubMed ID: 8404610
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pancreatic beta-cells expressing GLP-1 are resistant to the toxic effects of immunosuppressive drugs.
    D'Amico E; Hui H; Khoury N; Di Mario U; Perfetti R
    J Mol Endocrinol; 2005 Apr; 34(2):377-90. PubMed ID: 15821104
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exendin-4 and exendin-(9-39)NH2: agonist and antagonist, respectively, at the rat parietal cell receptor for glucagon-like peptide-1-(7-36)NH2.
    Schepp W; Schmidtler J; Riedel T; Dehne K; Schusdziarra V; Holst JJ; Eng J; Raufman JP; Classen M
    Eur J Pharmacol; 1994 Oct; 269(2):183-91. PubMed ID: 7851494
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic treatment with exendin(9-39)amide indicates a minor role for endogenous glucagon-like peptide-1 in metabolic abnormalities of obesity-related diabetes in ob/ob mice.
    Green BD; Irwin N; Gault VA; Bailey CJ; O'Harte FP; Flatt PR
    J Endocrinol; 2005 May; 185(2):307-17. PubMed ID: 15845923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of glucagon-like peptide-1 (GLP-1) receptor and the effect of GLP-1-(7-36) amide on insulin release by pancreatic islets during rat ontogenic development.
    García-Flores M; Zueco JA; Alvarez E; Blázquez E
    Eur J Biochem; 2001 Feb; 268(3):514-20. PubMed ID: 11168389
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Basal receptor activation by locally produced glucagon-like peptide-1 contributes to maintaining beta-cell function.
    Masur K; Tibaduiza EC; Chen C; Ligon B; Beinborn M
    Mol Endocrinol; 2005 May; 19(5):1373-82. PubMed ID: 15677711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. cAMP-dependent mobilization of intracellular Ca2+ stores by activation of ryanodine receptors in pancreatic beta-cells. A Ca2+ signaling system stimulated by the insulinotropic hormone glucagon-like peptide-1-(7-37).
    Holz GG; Leech CA; Heller RS; Castonguay M; Habener JF
    J Biol Chem; 1999 May; 274(20):14147-56. PubMed ID: 10318832
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exendin(9-39)amide is an antagonist of glucagon-like peptide-1(7-36)amide in humans.
    Schirra J; Sturm K; Leicht P; Arnold R; Göke B; Katschinski M
    J Clin Invest; 1998 Apr; 101(7):1421-30. PubMed ID: 9525985
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The glucagon-like peptide-1 receptor agonist oxyntomodulin enhances beta-cell function but does not inhibit gastric emptying in mice.
    Maida A; Lovshin JA; Baggio LL; Drucker DJ
    Endocrinology; 2008 Nov; 149(11):5670-8. PubMed ID: 18669601
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A cAMP and Ca2+ coincidence detector in support of Ca2+-induced Ca2+ release in mouse pancreatic beta cells.
    Kang G; Chepurny OG; Rindler MJ; Collis L; Chepurny Z; Li WH; Harbeck M; Roe MW; Holz GG
    J Physiol; 2005 Jul; 566(Pt 1):173-88. PubMed ID: 15860526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GLP-1 action in L6 myotubes is via a receptor different from the pancreatic GLP-1 receptor.
    Yang H; Egan JM; Wang Y; Moyes CD; Roth J; Montrose MH; Montrose-Rafizadeh C
    Am J Physiol; 1998 Sep; 275(3):C675-83. PubMed ID: 9730951
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glucagon stimulates exocytosis in mouse and rat pancreatic alpha-cells by binding to glucagon receptors.
    Ma X; Zhang Y; Gromada J; Sewing S; Berggren PO; Buschard K; Salehi A; Vikman J; Rorsman P; Eliasson L
    Mol Endocrinol; 2005 Jan; 19(1):198-212. PubMed ID: 15459251
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glucagon-like peptide-1-(7-36)amide increases pulmonary surfactant secretion through a cyclic adenosine 3',5'-monophosphate-dependent protein kinase mechanism in rat type II pneumocytes.
    Benito E; Blazquez E; Bosch MA
    Endocrinology; 1998 May; 139(5):2363-8. PubMed ID: 9564846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.